Funding source in Global project
Year:

none

Check the details 188(7.96%)

Self-funded

Check the details 131(5.55%)

Self-raised

Check the details 95(4.02%)

self-financing

Check the details 90(3.81%)

No

Check the details 33(1.40%)

self-funding

Check the details 22(0.93%)

Self-raised funds

Check the details 21(0.89%)

Sponsor

Check the details 21(0.89%)

Self-selected topic (self-funded)

Check the details 18(0.76%)

self-financed

Check the details 14(0.59%)

The First Hospital of Jilin University

Check the details 14(0.59%)

raise independently

Check the details 14(0.59%)

self-finance

Check the details 13(0.55%)

Self-selected Project (Self-funded)

Check the details 11(0.47%)

National natural science foundation of China

Check the details 8(0.34%)

National Key Research and Development Program of China

Check the details 7(0.30%)

Ministry of Science and Technology, China

Check the details 6(0.25%)

National Key Research and Development Program

Check the details 6(0.25%)

National Natural Science Foundation of China

Check the details 6(0.25%)

Self selected topic (self funded)

Check the details 6(0.25%)

Self financing

Check the details 6(0.25%)

Qyuns Therapeutics Co., Ltd.

Check the details 6(0.25%)

Other sponsor

Check the details 6(0.25%)

Chia Tai Tianqing Pharmaceutical Group Co,Ltd

Check the details 6(0.25%)

Foundations and self-financing

Check the details 6(0.25%)

Jilin University

Check the details 6(0.25%)

Optional Project (Self-Funded)

Check the details 5(0.21%)

Qilu Pharmaceutical Co., Ltd

Check the details 4(0.17%)

Research funds from the research leader

Check the details 4(0.17%)

Research Funding

Check the details 4(0.17%)

self-collected

Check the details 4(0.17%)

self-finacing

Check the details 4(0.17%)

self funded

Check the details 4(0.17%)

Self support

Check the details 4(0.17%)

National High Level Hospital Clinical Research Funding

Check the details 4(0.17%)

Self-selected topic

Check the details 4(0.17%)

The key project of the national key research and development plan

Check the details 4(0.17%)

First Hospital of Jilin University

Check the details 4(0.17%)

Chia Tai Tianqing Pharmaceutical Group Co,Ltd

Check the details 4(0.17%)

Completely self-funded

Check the details 4(0.17%)

Department of Science and technology of Jilin Province

Check the details 4(0.17%)

Thirteenth Five-Year National Science and Technology Major project funding

Check the details 4(0.17%)

Wu Jieping Medical Foundation

Check the details 4(0.17%)

China Primary Health Care Foundation

Check the details 3(0.13%)

Clinical Research Project of Liaoning Diabetes Medical Nutrition Prevention Society

Check the details 3(0.13%)

creative funding of Jilin University

Check the details 3(0.13%)

Beijing Medical Award Foundation

Check the details 3(0.13%)

At sponsor's own expense

Check the details 3(0.13%)

By oneself

Check the details 3(0.13%)

Funded project

Check the details 3(0.13%)

Fully self-funded

Check the details 3(0.13%)

Jilin Provincial Science & Technology Department, China

Check the details 3(0.13%)

Jilin Provincial Science & Technology Department, China (No.20230203100SF)

Check the details 3(0.13%)

Jiangsu Kanion Pharmaceutical Co., Ltd.

Check the details 3(0.13%)

Technology Innovation Guidance Program

Check the details 3(0.13%)

Technological innovation incubation program of Jilin province

Check the details 3(0.13%)

Shandong Luye Pharmaceutical Co., Ltd.

Check the details 3(0.13%)

National Key R&D Program of China

Check the details 3(0.13%)

National Key R&D Program of China

Check the details 3(0.13%)

National Key Research and Development Program: TCM rehabilitation of major dysfunction after apoplexy (2018YFC1706006)

Check the details 3(0.13%)

No funding

Check the details 3(0.13%)

No.

Check the details 3(0.13%)

Self selected topic

Check the details 3(0.13%)

Self

Check the details 3(0.13%)

Provided by the sponsor

Check the details 3(0.13%)

Not stated

Check the details 3(0.13%)

Null

Check the details 3(0.13%)

Project of Jilin Development and Reform Commission

Check the details 3(0.13%)

personal expenses

Check the details 2(0.08%)

NOT

Check the details 2(0.08%)

Not Applicable

Check the details 2(0.08%)

Not involved

Check the details 2(0.08%)

Own expense

Check the details 2(0.08%)

Own funding

Check the details 2(0.08%)

Pediatric Pneumonia Inheritance and Innovation Platform Construction Project (2020-1)

Check the details 2(0.08%)

Project funding

Check the details 2(0.08%)

secondary sponsor

Check the details 2(0.08%)

Self finance

Check the details 2(0.08%)

Scientific research funding for Traditional Chinese Medicine (2009), Yiling Pharmaceutical Group

Check the details 2(0.08%)

Research Project of Norman Bethune Plan of Jilin University

Check the details 2(0.08%)

Scientific research project of Jilin University (3r2168633428)

Check the details 2(0.08%)

self funding

Check the details 2(0.08%)

Self raised

Check the details 2(0.08%)

Self raised funds

Check the details 2(0.08%)

Qyuns Therapeutics Co., Ltd.

Check the details 2(0.08%)

raise independently

Check the details 2(0.08%)

Other

Check the details 2(0.08%)

Research funds for doctoral students

Check the details 2(0.08%)

Research funds from the research leader

Check the details 2(0.08%)

Sanofi (China) Investment Co., Ltd. Shanghai Branch

Check the details 2(0.08%)

Sanofi (Beijing) Pharmaceutical Co., Ltd.

Check the details 2(0.08%)

Sanofi (Beijing) Pharmaceuticals Co., Ltd

Check the details 2(0.08%)

Science and Technology Department of Jilin Province - Prevention and treatment project of ventricular remodeling after acute myocardial infarction

Check the details 2(0.08%)

Researcher self-funded

Check the details 2(0.08%)

Researcher-initiated topics

Check the details 2(0.08%)

Researcher-initiated project

Check the details 2(0.08%)

Science and Technology Development Program of Jilin Province (No. 20200201592JC)

Check the details 2(0.08%)

Science and Technology Innovation Project of China Academy of Chinese Medical Sciences

Check the details 2(0.08%)

National Key Technologies R&D Program, Modernization of Traditional Chinese Medicine of Ministry of Science and Technogy of the People's Republic of China (Project No. 2017YFC1700500)

Check the details 2(0.08%)